▁British 10.375
▁Bi 10.859375
ote 5.58203125
ch 4.43359375
' 7.37109375
s 1.0361328125
▁Can 5.2734375
cer 1.4375
▁D 4.67578125
rug 3.837890625
▁Sh 8.015625
ows 3.701171875
▁Pos 8.171875
itive 1.9892578125
▁Results 4.96484375
▁but 9.421875
▁Anal 9.0859375
yst 3.07421875
s 1.5078125
▁Ur 8.6640625
ge 2.802734375
▁Ca 5.81640625
ution 0.0860595703125
▁▁ 10.8125
<0x0A> 2.009765625
<0x0A> 1.43359375
Bi 6.37109375
ote 1.2421875
ch 1.8173828125
▁startup 5.75
▁On 10.1015625
co 0.57373046875
Sol 7.4140625
utions 1.294921875
▁today 5.96484375
▁announced 0.478759765625
▁positive 7.3828125
▁results 0.552734375
▁from 0.5029296875
▁a 1.00390625
▁Ph 0.947265625
ase 0.0008730888366699219
▁ 0.83837890625
2 1.25390625
▁trial 1.7802734375
▁of 0.6298828125
▁its 0.5048828125
▁experimental 4.08984375
▁cancer 1.7041015625
▁drug 0.9287109375
▁OS 6.1484375
C 2.859375
- 0.39306640625
4 3.0703125
3 2.595703125
. 4.078125
▁The 1.1025390625
▁drug 0.94873046875
▁showed 3.291015625
▁tum 5.24609375
or 0.353271484375
▁shr 0.26806640625
ink 0.052734375
age 0.004085540771484375
▁in 0.52685546875
▁ 1.064453125
6 2.17578125
5 2.23046875
% 1.0439453125
▁of 0.0197601318359375
▁patients 0.464599609375
▁with 1.2431640625
▁advanced 1.8544921875
▁pan 2.845703125
cre 0.0007653236389160156
atic 0.0286407470703125
▁cancer 0.1121826171875
, 1.1484375
▁a 2.92578125
▁dead 4.05859375
ly 0.007045745849609375
▁disease 1.0234375
▁with 1.677734375
▁few 2.234375
▁treatment 0.7685546875
▁options 0.00860595703125
. 0.275634765625
▁However 4.02734375
, 0.07562255859375
▁industry 9.6484375
▁anal 1.2509765625
yst 0.00101470947265625
s 0.04107666015625
▁war 3.21875
ned 0.0030651092529296875
▁that 0.57958984375
▁the 0.6044921875
▁results 1.4033203125
, 3.66015625
▁while 2.580078125
▁encourag 1.44140625
ing 0.00043392181396484375
, 0.04522705078125
▁require 6.421875
▁further 1.1806640625
▁validation 2.966796875
▁before 2.130859375
▁determ 7.05859375
ining 0.006580352783203125
▁the 1.556640625
▁drug 0.57958984375
' 0.273681640625
s 0.0002167224884033203
▁potential 2.03515625
. 1.6650390625
▁▁ 4.37890625
<0x0A> 0.111083984375
<0x0A> 0.32568359375
In 3.23046875
▁the 1.2763671875
▁trial 1.033203125
▁of 3.505859375
▁ 0.86962890625
4 2.220703125
7 2.966796875
▁patients 0.123291015625
, 0.59765625
▁OS 1.16796875
C 0.00270843505859375
- 0.00792694091796875
4 0.004444122314453125
3 0.0018548965454101562
▁stopped 6.25
▁tum 0.73046875
or 0.205810546875
▁growth 0.1795654296875
▁for 3.748046875
▁a 2.501953125
▁median 0.1800537109375
▁of 0.0972900390625
▁ 0.25439453125
4 2.501953125
. 0.293212890625
2 2.24609375
▁months 0.2412109375
. 1.765625
▁ 3.212890625
3 3.107421875
0 2.11328125
▁patients 1.376953125
, 3.703125
▁or 1.6513671875
▁ 0.1842041015625
6 0.0841064453125
5 3.08203125
%, 0.360107421875
▁showed 2.080078125
▁a 1.98828125
▁reduction 2.6484375
▁in 0.2110595703125
▁tum 0.2161865234375
or 0.048614501953125
▁size 0.6328125
▁of 1.978515625
▁at 0.61328125
▁least 0.000720977783203125
▁ 0.0849609375
3 1.716796875
0 0.1754150390625
%. 0.95751953125
▁On 5.171875
co 0.158203125
Sol 0.005245208740234375
utions 0.039459228515625
▁CE 2.33203125
O 0.0005435943603515625
▁Jane 7.90234375
▁Smith 5.6328125
▁said 0.6796875
, 2.533203125
▁" 0.12139892578125
We 1.4248046875
▁are 0.85791015625
▁thr 3.177734375
illed 3.7670135498046875e-05
▁with 0.91943359375
▁these 0.97509765625
▁results 0.7900390625
▁for 4.75
▁a 3.07421875
▁disease 3.7578125
▁that 0.93359375
▁usually 5.88671875
▁has 1.4267578125
▁a 1.48046875
▁very 2.064453125
▁poor 0.58984375
▁pro 0.2005615234375
gn 9.202957153320312e-05
osis 0.0002620220184326172
. 1.275390625
▁OS 3.818359375
C 0.0034503936767578125
- 0.01004791259765625
4 0.002918243408203125
3 0.0009732246398925781
▁could 4.1484375
▁be 0.99462890625
▁a 0.5419921875
▁much 4.93359375
- 0.57861328125
ne 0.0075531005859375
eded 0.00016379356384277344
▁new 1.6357421875
▁treatment 0.5986328125
▁option 0.5361328125
▁for 0.336669921875
▁pan 1.5380859375
cre 0.0004172325134277344
atic 0.0048828125
▁cancer 0.02484130859375
▁patients 0.541015625
." 0.57763671875
▁The 3.333984375
▁company 1.40625
▁a 5.60546875
ims 0.04254150390625
▁to 0.032440185546875
▁move 3.58203125
▁the 0.44970703125
▁drug 0.163330078125
▁into 0.56005859375
▁a 1.5537109375
▁larger 2.05078125
▁Ph 0.75830078125
ase 0.00028228759765625
▁ 0.0452880859375
3 0.0806884765625
▁trial 0.4560546875
▁next 2.48828125
▁year 0.04742431640625
. 0.31689453125
▁▁ 1.66015625
<0x0A> 0.0131378173828125
<0x0A> 0.052490234375
Pan 4.96484375
cre 0.00608062744140625
atic 0.00926971435546875
▁cancer 0.059173583984375
▁is 0.454833984375
▁the 1.1259765625
▁fourth 0.7109375
▁leading 1.1171875
▁cause 0.02496337890625
▁of 0.00586700439453125
▁cancer 0.0653076171875
▁death 0.51611328125
s 1.2265625
▁world 2.33203125
wide 0.006725311279296875
, 0.68017578125
▁with 1.056640625
▁a 1.84375
▁five 0.75341796875
- 0.0718994140625
year 0.0015783309936523438
▁surv 0.06573486328125
ival 0.0006117820739746094
▁rate 0.02911376953125
▁of 0.09295654296875
▁just 1.49609375
▁ 0.0947265625
9 2.025390625
%. 0.466552734375
▁Ex 7.40625
isting 0.61376953125
▁treat 1.015625
ments 6.377696990966797e-05
▁are 1.51953125
▁limited 1.7548828125
, 1.88671875
▁creating 9.09375
▁a 0.6455078125
▁" 3.943359375
high 4.578125
▁un 0.64208984375
met 0.0006384849548339844
▁need 1.0458984375
" 1.162109375
▁that 2.74609375
▁new 7.54296875
▁dru 0.98095703125
gs 3.993511199951172e-05
▁like 1.4541015625
▁OS 0.20947265625
C 0.0003724098205566406
- 0.00385284423828125
4 0.0010957717895507812
3 0.0004756450653076172
▁aim 2.84375
▁to 0.0067138671875
▁address 0.4892578125
. 0.6591796875
▁However 4.12890625
, 0.00598907470703125
▁anal 2.58203125
yst 0.00152587890625
s 0.036285400390625
▁war 2.1328125
ned 0.0006475448608398438
▁invest 7.80859375
ors 0.00727081298828125
▁not 2.515625
▁to 0.00542449951171875
▁get 1.2939453125
▁ahead 2.69921875
▁of 0.0024204254150390625
▁themselves 0.48779296875
▁based 4.9609375
▁on 0.0164337158203125
▁a 2.9765625
▁single 0.68701171875
▁Ph 0.94775390625
ase 9.632110595703125e-05
▁ 0.004974365234375
2 0.0016393661499023438
▁study 2.09375
. 0.36474609375
▁ 1.9443359375
<0x0A> 0.5205078125
<0x0A> 0.051666259765625
" 1.3828125
The 1.8203125
▁data 2.986328125
▁looks 5.8203125
▁good 2.01171875
▁so 5.234375
▁far 0.09771728515625
▁but 2.83203125
▁it 1.9619140625
' 0.73291015625
s 0.005367279052734375
▁still 2.65625
▁very 2.779296875
▁early 0.1417236328125
▁days 1.267578125
," 0.73681640625
▁said 0.474365234375
▁David 4.03125
▁Jones 5.26171875
, 0.1510009765625
▁an 1.3408203125
▁on 3.89453125
colog 1.337890625
ist 0.01177215576171875
▁and 1.0048828125
▁man 5.5859375
aging 0.00010228157043457031
▁director 0.441162109375
▁at 0.69140625
▁bi 4.57421875
ote 0.036529541015625
ch 0.12548828125
▁invest 0.93994140625
ment 0.329833984375
▁bank 1.8212890625
▁Al 5.76171875
pha 2.06640625
B 5.8984375
io 1.02734375
▁Part 3.962890625
ners 0.00028204917907714844
. 0.24658203125
▁" 0.380615234375
Ph 6.296875
ase 0.021087646484375
▁ 0.01788330078125
2 0.5537109375
▁studies 1.947265625
▁are 0.61083984375
▁designed 2.9375
▁to 0.05194091796875
▁show 1.40625
▁if 3.37890625
▁a 0.58203125
▁drug 0.46630859375
▁works 1.55078125
, 1.28125
▁but 1.044921875
▁larger 8.1640625
▁tri 1.8310546875
als 4.112720489501953e-05
▁are 0.73486328125
▁needed 0.548828125
▁to 0.11346435546875
▁confirm 2.01953125
▁effic 2.072265625
acy 2.3484230041503906e-05
▁and 0.8212890625
▁determine 2.2890625
▁long 4.84765625
- 0.0183868408203125
term 0.0014524459838867188
▁benefits 2.349609375
. 1.3115234375
▁Many 5.3828125
▁once 10.953125
- 0.314697265625
prom 0.5
ising 0.0008106231689453125
▁treat 2.90234375
ments 3.993511199951172e-05
▁have 0.712890625
▁st 4.72265625
umbled 1.939453125
▁in 1.5126953125
▁Ph 2.255859375
ase 0.0006628036499023438
▁ 0.0008311271667480469
3 0.193359375
." 2.87109375
▁Jones 3.501953125
▁estimates 6.74609375
▁OS 2.279296875
C 0.0006313323974609375
- 0.0035457611083984375
4 0.0010423660278320312
3 0.0005269050598144531
▁has 2.171875
▁a 0.5283203125
▁ 1.123046875
3 2.30859375
0 0.4736328125
- 2.681640625
5 1.1572265625
0 0.003444671630859375
% 0.007694244384765625
▁chance 0.1024169921875
▁of 0.0230712890625
▁eventually 4.58203125
▁being 1.7861328125
▁approved 0.2744140625
. 1.7802734375
<0x0A> 1.4404296875
<0x0A> 0.036224365234375
On 3.099609375
co 0.07958984375
Sol 0.002391815185546875
utions 0.01136016845703125
▁will 3.61328125
▁expand 5.3203125
▁its 1.1220703125
▁Ph 1.08984375
ase 0.0010251998901367188
▁ 0.003314971923828125
3 2.298828125
▁trial 0.5380859375
▁from 3.10546875
▁ 0.2164306640625
2 2.337890625
0 1.0986328125
0 1.4306640625
▁to 1.0625
▁ 0.09368896484375
6 2.697265625
0 0.07684326171875
0 0.00849151611328125
▁patients 0.09197998046875
▁across 5.3984375
▁multiple 3.19140625
▁countries 2.587890625
. 1.2158203125
▁" 3.51953125
This 2.37109375
▁will 2.380859375
▁reduce 7.04296875
▁the 0.384033203125
▁chance 3.673828125
▁of 0.15283203125
▁an 3.853515625
▁anom 9.3046875
alous 2.31640625
▁result 1.8740234375
▁and 2.130859375
▁ensure 3.650390625
▁the 1.8076171875
▁find 5.82421875
ings 7.140636444091797e-05
▁hold 4.3046875
▁up 0.6083984375
," 2.095703125
▁Smith 1.6171875
▁said 0.08819580078125
. 0.0889892578125
▁The 2.220703125
▁company 0.55224609375
▁hopes 3.96484375
▁to 0.27880859375
▁submit 3.3984375
▁OS 4.875
C 0.0008420944213867188
- 0.0009555816650390625
4 0.0008454322814941406
3 0.0005421638488769531
▁for 0.53369140625
▁regul 2.091796875
atory 0.0005373954772949219
▁appro 0.2568359375
val 0.0001360177993774414
▁in 0.607421875
▁ 0.9208984375
2 0.01071929931640625
0 0.0027141571044921875
2 0.36474609375
3 1.6103515625
▁if 5.078125
▁the 0.54833984375
▁larger 4.08203125
▁trial 0.94482421875
▁confir 2.470703125
ms 4.887580871582031e-06
▁the 0.9658203125
▁Ph 1.2685546875
ase 0.00046539306640625
▁ 0.0011615753173828125
2 0.00402069091796875
▁out 6.53125
comes 0.002948760986328125
. 0.0859375
<0x0A> 0.6416015625
<0x0A> 0.0181732177734375
Wh 6.72265625
ile 0.0302734375
▁the 1.431640625
▁On 6.9765625
co 0.019134521484375
Sol 0.004085540771484375
utions 0.0141448974609375
▁results 3.6640625
▁are 0.859375
▁an 4.8828125
▁encourag 0.267578125
ing 0.005062103271484375
▁sign 0.755859375
▁of 2.87109375
▁progress 1.0771484375
, 0.94921875
▁the 1.73046875
▁real 7.1640625
▁work 3.673828125
▁lies 1.6650390625
▁ahead 0.271240234375
▁in 2.689453125
▁rig 7.13671875
or 0.779296875
ously 0.0006327629089355469
▁demonstr 3.15625
ating 5.698204040527344e-05
▁whether 4.9140625
▁OS 0.7177734375
C 0.0008077621459960938
- 0.0017328262329101562
4 0.0008764266967773438
3 0.00039458274841308594
▁significantly 5.3671875
▁impact 4.56640625
s 0.0012187957763671875
▁surv 2.166015625
ival 0.00176239013671875
▁and 2.125
▁quality 1.4287109375
▁of 0.1407470703125
▁life 0.001216888427734375
▁for 1.345703125
▁pan 2.197265625
cre 0.0002644062042236328
atic 0.00411224365234375
▁cancer 0.0084991455078125
▁patients 0.005397796630859375
. 0.36181640625
▁Anal 4.8203125
yst 0.0037746429443359375
s 0.02276611328125
▁and 3.802734375
▁invest 0.49658203125
ors 0.0041961669921875
▁will 1.6591796875
▁be 1.21875
▁eager 4.046875
ly 0.67529296875
▁await 0.89892578125
ing 0.004978179931640625
▁the 0.787109375
▁Ph 3.216796875
ase 0.0002796649932861328
▁ 0.0008211135864257812
3 0.01016998291015625
▁data 1.58984375
▁before 6.0078125
▁passing 5.4453125
▁final 2.119140625
▁judgment 0.399658203125
▁on 0.6689453125
▁the 0.381591796875
▁drug 0.5078125
' 1.09765625
s 0.0017452239990234375
▁potential 0.473876953125
. 0.2255859375
▁For 5.96875
▁now 1.041015625
, 0.01383209228515625
▁optim 6.35546875
ism 0.1976318359375
▁should 5.01171875
▁remain 1.609375
▁c 4.91015625
aut 0.0006613731384277344
ious 0.176025390625
. 0.87158203125
